Wearable Neurostimulation

For Opioid Withdrawal Relief

Safe Science Solutions is the exclusive Canadian distributor and licensed provider of the device in America through select clinic chains.

Opioid Epidemic: Societal Issue Without A Solution

Lives Impacted

0 M
Americans who struggle with Opioid Use Disorder (OUD)
Opioid Overdose Deaths in 2021
Babies born dependent annually

Treatment Barriers

2 Out of 5

Won’t seek care due to fear of withdrawal

>21 Yrs.

With existing beds, time current system needs to detox OUD pop.4

Opioid Withdrawal Treatment Challenges

What if you had an opioid withdrawal treatment that offered:

Less Complexity

More Flexibility

Introducing Sparrow Ascent

FDA-Cleared Safe, Comfortable, Drug-Free

Providing Total Value

Sparrow Ascent Drives Organization Wide Opportunity To Enhance Care

Evidence Based

Level 1, RCT NIH: NIDA Published


Non-Addictive, No Diversion Risk, No Known Side Effects

Patient Control

5 Min Activation, No Needed Withdrawal, Zero Needles

Any Setting

No X-Waiver Hosp. to Home Alone or Added


>50% ↓ in 60 Min 100% of Patients COWS, PCL-5, PHQ-9


Robust Training Dedicated Team 24/7 Care

What's Included

Everything Needed for Therapy - All In One Kit


28 Comfortable Daily Disposable Earpieces

They’re easy to apply, just like a sticker, and deliver mild electrical stimulation to the nerves on and around the ear.

Patient Controller

Easy-to-Use Patient Controller

It powers the Earpiece and puts the patient in control of the duration and level of stimulation needed for relief.



It connects and delivers electrical pulses from the Patient Controller to the Earpiece.

Sparrow Ascent Is



Drug Free

How It Works

1 Meade, C.S., Lucas, S.E., McDonald, L.J., Fitzmaurice, G.M., Eldridge, J.A., Merrill, N., Weiss, R.D., (2010) A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. Journal of Substance Abuse Treatment, 38(1), 12-21., Han, J. S., & Wang, Q. (1992). Mobilization of specific neuropeptides by peripheral stimulation of identified frequencies. Physiology, 7(4), 176-180., Qureshi, I. S., Datta-Chaudhuri, T., Tracey, K. J., Pavlov, V. A., & Chen, A. C. (2020). Auricular neural stimulation as a new non-invasive treatment for opioid detoxification. Bioelectronic medicine, 6(1), 1-8., Jenkins, D. D., Khodaparast, N., O’Leary, G. H., Washburn, S. N., Covalin, A., & Badran, B. W. (2021). Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome. Frontiers in Human Neuroscience, 15, 110.

No Pills, No Needles, Just Results

Backed By A Level 1 Clinical Trial

84% of participants experienced mild or no withdrawal symptoms after 60 minutes of therapy.
100% of participants sustained a clinically meaningful reduction in withdrawal symptoms by day 3.
9 out of 10 participants who completed detox accepted a referral to continue opioid use disorder treatment.

COWS Reduction Throughout Detox

Significant OPIOID Withdrawal Symptom Relief In As Little As 30 Minutes.

PHQ-9 and PCL-5 Results

Helping Support The Recovery Journey

Clinical trial participants also experienced reduction in Depression and PTSD

PHQ-9 = Depression
42.9% of participants had clinically meaningful reduction in PHQ-9 scores at day 5
35.7% of participants had clinically meaningful reduction in PCL-5 scores at day 5